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The effect of chemical modification at the Cl position of GLA-27,4-O-phosphono-D-glucosamine carrying N-3-tetrade- 
canoyloxytetradecanoyl [C,,-0-(C,,)] and 30tetradecanoyl (C,,) groups, was investigated. Replacement by SH or S- 
acetyl groups of the OH group resulted in the enhancement of mitogenicity but gave rise to a reduction, in macrophage- 
stimulating ability such as induction of tumor necrosis factor and enhancement of phagocytic and cellular acid phospha- 
tase activities. Bisphosphorylation at Cl and C4 resulted in a slight decrease in mitogenicity or almost complete loss 
of the macrophage-stimulating ability. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Various immunopharmacological activities of 
lipid A, the active principle of endotoxin, are 
manifested by chemically synthesized lipid A- 
subunit analogs, 4-0-phosphono-D-glucosamine 
derivatives carrying N- and 3-0-acyl substituents 
[l]. GLA-27, a glucosamine derivative with 4-0- 
phosphoryl, 3-0X14 and N-CWO-(C14) groups, is 
a prototype compound fulfilling the structural re- 
quirements for the expression of immunophar- 
macological activity without pyrogenicity and 
Shwartzman reaction [2-B]. 
The present investigation was undertaken in 
order to determine whether chemical modification 
at Cl of the glucosamine backbone of GLA-27 ex- 
erts an influence on the expression of im- 
munopharmacological activity. 
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2.1. Synthetic and natural compounds 
Lipid A-subunit analogs were synthesized chemically as in 
[9]. The chemical structures of the synthetic compounds are 
depicted in fig.1. Natural lipid A prepared from Escherichia 
co/i F-515 (Re) was kindly donated by Drs 0. Liideritz and C. 
Galanos (Max-Planck-Institut fiir Immunobiologie, Freiburg, 
FRG) and used as a positive control. Samples were solubilized 
in pyrogen-free water by treatment with triethylamine and com- 
plexing with bovine serum albumin as described in [2]. 
2.2. Mitogenic activity 
Mitogenic activity was assessed by determining tritiated 
thymidine ([3H]TdR) uptake into C3H/He spleen cells (4 x 10’ 
cells/well of 96well microplate) which were incubated in 
triplicate at 37°C for 48 h with or without test samples [lo]. 
2.3. Tumor-necrosis factor (TNF)-inducing activity 
TNF-inducing activity was assessed by determining TNF titer 
in sera obtained from Propionibacterium acnes-primed mice 
which had been administered intravenously lo-pg test samples 
1.5 h earlier, according to [4]. TNF titer was determined by 
measuring the percent inhibition of [‘H]TdR uptake into L-929 
cells. 
2.4. Macrophage-activating activity 
The ability of peritoneal macrophages, obtained from 
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Fig. 1. Chemical structures of lipid A-subunit analogs. 
Compound R’ (l-) R2 (N-) R’ (3-O-) 
GLA-21 
GLA-65 
GLA-66 
GLA-70 
-OH -c14-o-(C14) 
-S-COCH3 -c14-o-(C14) 
-SH -c14-o-(Cl‘+) 
-0-PO(OH)2 -C140(C14) 
-C14 
-cl4 
-c14 
-C14 
(BALB/c x DBA/2)Fr (CDF,) mice which had been ad- 
ministered i.p. 20,ug of test samples 4 days earlier, was in- 
vestigated as in [7]. Phagocytic activity was assessed by 
evaluating the radioactivity of “0-labeled and antibody- 
sensitized sheep erythrocytes which were phagocytosed by 
peritoneal macrophages (5 x 10’ cells/well, 24-well culture 
tray). Cellular lysosomal enzyme (acid phosphatase) activity of 
peritoneal macrophages (1 x lo5 cells/well of 96-well 
microplate) was assayed as follows: macrophage lysates were 
mixed with 0.2 M acetate buffer, 24 mM p-nitrophenyl 
phosphate and incubated at 37°C for 30 min; 0.2 M sodium 
carbonate was then added to the reaction mixture and the ab- 
sorbance at 405 nm estimated. Enzyme activity was calculated 
from the standard curve using acid phosphatase from potato. 
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Fig.2. Mitogenic activity of lipid A-subunit analogs. C3H/He 
spleen cells were stimulated for 48 h with the indicated dose of 
natural lipid A (0), GLA-27 (v), GLA-65 (A), GLA-66 (0) 
and GLA-70 (a). Mock control (0). Mitogenic activity is 
expressed as cpm (means f SD) of triplicate cultures. [Lipid A] 
80366 f 7284 (1 pg/well) and 82277 f 2322 (IO,~g/well). 
2500 12500 62500 
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Fig.3. TNF-inducing activity of lipid A-subunit analogs. Sera 
were obtained from mice administered i.v. natural lipid A (o), 
GLA-27 (v), GLA-65 (A), GLA-66 (0) or GLA-70 (+) at a 
dose of 10 fig per mouse. Mock control (0). TNF activity in 
sera is expressed as percent inhibition of [‘H]TdR uptake into 
L-929 cells. 
3. RESULTS 
Our results on mitogenic activity are shown in 
fig.2. An increase in mitogenic activity at a dose of 
10 pug/well was found to result from the replace- 
ment by either an SH or S-AC group of the OH 
group at Cl of GLA-27. Mitogenic activity of 
compound (GLA-70) bisphosphorylated at Cl and 
C4 was somewhat weaker than that of GLA-27. 
As reported in [2,4,5,8], GLA-27 exhibited 
significant TNF-inducing activity; however, the ac- 
Table I 
Phagocytic activity of peritoneal macrophages timulated in 
vivo’with lipid A-subunit analogs 
Compounds Phagocytosis (W)” 
Expt 1 Expt 2 Mean 
Control 1.2 f 0.1 0.9 + 0.1 1.1 
Lipid A 5.0 + 0.2’ 5.1 + 0.2’ 5.1 
GLA-27 3.1 + 0.3’ 3.5 + o.2c 3.3 
GLA-65 2.0 + 0.3b 2.6 k 0.1’ 2.3 
GLA-66 1.8 f 0.2b 2.1 * O.lC 2.0 
GLA-70 1.3 + 0.1”” 1.1 * o.ln5 1.2 
a Results are expressed as arithmetic mean + SD of triplicate 
cultures; b P < 0.01 and ’ P < 0.001 (by Student’s t-test); “s, not 
significant 
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Table 2 
Cellular lysosomal enzyme activity of peritoneal macrophages 
stimulated in vivo with lipid A-subunit analogs 
Compounds Acid phosphatase activity (mU/ld cells)” 
Expt 1 Expt 2 Mean 
Control 593 * 13 613 * 50 606 
Lipid A 1093 + ISOd 1124 + 65d 1109 
GLA-27 802 + 65’ 831 + 71d 820 
GLA-65 708 f 20b 693 + 30d 701 
GLA-66 670 i 12”’ 635 + 30”’ 653 
GLA-70 613 * 20”’ 629 * 13”’ 621 
a Results are expressed as arithmetic mean + SD of triplicate 
cultures; b P < 0.05, ’ P < 0.01 and d P < 0.001 (by Student’s 
t-test); “’ not significant 
tivity was weaker than that of natural lipid A 
(fig.3). Decreased TNF-inducing activity was 
observed in GLA-65 with an S-AC group at Cl. 
The activity of GLA-66 with an SH group was very 
weak. GLA-70 with 1,6bisphosphates howed no 
detectable activity. 
With respect to macrophage activation, the 
results concerning the phagocytic activity are listed 
in table 1. Natural lipid A induced a marked 
enhancement of phagocytosis of peritoneal 
macrophages in both experiments. Peritoneal 
macrophages from mice administered GLA-27 
showed significant phagocytic activity. The ac- 
tivities of GLA-65 and GLA-66 were weaker than 
that of GLA-27. Administration of GLA-70 did 
not enhance the activity. As shown in table 2, the 
largest increase in level of cellular acid 
phosphatase activity was observed in peritoneal 
macrophages recovered from mice which had been 
administered lipid A. Significant acid phosphatase 
activity was observed in GLA-27 and GLA-65 but 
not in GLA-66 and GLA-70. 
4. DISCUSSION 
Previous studies showed that biological activities 
of I-deoxy compound of GLA-27, GLA40, were 
somewhat stronger than GLA-27 in expression of 
mitogenicity and polyclonal B cell activation but 
almost equal to those of GLA-27 in terms of 
macrophage activation, TNF-inducing activity and 
enhancement of antiviral activities against vaccinia 
virus infection [5,6]. The present study shows that 
chemical modification at the Cl position of the 
glucosamine backbone has varied effects on the ac- 
tivities of GLA-27. Replacement by an SH or S-AC 
group of the OH group at Cl of GLA-27 induced 
an increase in tiitogenicity but caused a reduction 
in macrophage-stimulating activity. The activities 
of GLA-65 with an S-AC group were greater than 
those of GLA-66 which contains an SH group. 
This distinction indicates that different structural 
requirements for activation of lymphocytes and 
macrophages exist in the lipid A-subunit analog. 
Ikeda and colleages [ll] reported that GLA-66 
with an SH group was less effective compared to 
GLA-27 in enhancing the effect of nonspecific 
resistance in mice against vaccinia virus infection, 
in which nonspecific phagocytes participate as ef- 
fector cells for viral clearance [111. The above sug- 
gests that the introduction of an SH group at the 
Cl position can reduce the ability of the analog to 
induce nonspecific phagocytes which participate as 
effector cells for eliminating invaded pathogens. 
A previous study indicated that phosphorylation 
at Cl of the glucosamine backbone is more effec- 
tive for expression of lymphocyte activation than is 
phosphorylation at C4 [6]. Among the synthetic 
lipid A analogs which are glucosamine disac- 
charide compounds, compound 506, which is 
bisphosphorylated at Cl and C4’, demonstrated 
stronger biological and toxic activities compared 
to compounds 504 and 505, which are 
monophosphorylated at Cl or C4’ [12]. However, 
bisphosphorylation at Cl and C4 in the 
glucosamine monosaccharide resulted in a slight 
decrease in mitogenic activity or almost complete 
loss of TNF-inducing activity and macrophage ac- 
tivation, suggesting that 1,4-bisphosphorylation is
the excess of negative charge in the monosac- 
charide compound for manifesting the activities. 
A number of lipid A-subunit analogs retain par- 
ticular biological activities of endotoxin without a 
toxic effect being exerted, such as pyrogenicity and 
local Shwartzman reaction. Further experimenta- 
tion is required in order to clarify the structural re- 
quirements for the expression of a limited 
beneficial activity in host defense. 
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